Abstract:Objective To explore the association between a phase Ⅰ drug metabolizing enzyme encoding gene Cytodrome P450 2E1 (CYP2E1) and a phase Ⅱ drug metabolizing enzyme encoding gene UDP-glucuronosyltransferase 1 (UGT1A1) and susceptibility of first-line anti-tuberculous drug induced liver injury (ATDILI).Methods Four hundred and sixty-one patients with ATDILI and 466 patients with non-ATDILI who were hospitalized in Shanghai Pulmonary Hospital from March 2012 to December 2015 were included in this study.The clinical characteristics of the two groups were compared.A whole blood sample was collected from each patient for genomic DNA extraction and genotype analysis.Fourteen tagSNPs of UGT1A1 and CYP2E1 gene were selected using systematic bioinformatic analysis (Hardy-Weinberg Equilibrium (HWE)-P＞0.001,Minimum-allele Frequency ＞0.1,r2＞0.8).We performed a population based case-control study to genotype the 14 tagSNPs of UGT1A1 and CYP2E1 gene using SNPscanTM technology.The genotype and haplotype frequencies were detected and compared between the two groups.Three genetic models including dominant,recessive and additive model were used to analyze the association between all the selected SNPs polymorphisms and susceptibility of ATDILI.Results All the alleles frequencies of these SNPs were in HWE.We found that in ATDILI group,the frequency of UGT1A1 rs4148323 AA genotype (1.7％,8/461) was significantly lower than that in non ATDILI group (4.3％,20/466),which indicated that the rs4148323 A/A carriers had a decreased risk for developing ATDILI (OR=0.37,95％CI=0.16-0.86,P=0.020).In recessive model,rs4148323 A/A was also associated with a decreased risk for ATDILI (OR=0.39,95 ％CI=0.17-0.90,P=0.023).In additive model,allele of rs4148323 minor A was found to be associated with risk reduction with ATDILI (OR =0.79,95 ％ CI=0.63 0.99,P=0.040).Haplotype analysis showed the frequency of ATG haplotype of UGT1A1 gene in ATDILI group (0.19) were significantly lower than that in non ATDILI group (0.22),which demonstrated that ATG haplotype was related to the decreasing of ATDILI incidence (OR=0.79,95％CI=0.63-0.99,P=0.045).We didn't find any other SNP that was associated with ATDILI.Concision Our study showed that UGT1A1 gene is a susceptibility gene of ATDILI in Chinese Han population.

Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment

Study on Hereditary Susceptibility Genetic Markers to Anti-Tuberculosis Drug Induced Liver Injury in Chinese Population

Prospective Study Of Aldh1a1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury In Western Chinese Han Population

Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.

Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort

The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.

Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case–Control Study

Genome-Wide Analysis of DNA Methylation and Antituberculosis Drug-Induced Liver Injury in the Han Chinese Population

Association between UGT1A1 and CYP2E1 gene polymorphisms and susceptibility of first-line anti-tuberculous drug induced liver injury

Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.

Association of ABCC Gene Polymorphism with Susceptibility to Antituberculosis Drug–Induced Hepatotoxicity in Western Han Patients with Tuberculosis

Pharmacogenetic Study Of Drug-Metabolising Enzyme Polymorphisms On The Risk Of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis

Role of Polymorphic Bile Salt Export Pump (BSEP, ABCB11) Transporters in Anti-Tuberculosis Drug-Induced Liver Injury in a Chinese Cohort

[Study on the Correlation Between Polymorphisms of Genes with Susceptibility to Tuberculosis and Drug-Resistant Tuberculosis in Chinese Han Population].

Association of POR and PPARα Polymorphisms with Risk of Anti-Tuberculosis Drug-Induced Liver Injury in Western Chinese Han Population

Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis

Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study

Absence of Significant Association Between UGT2B4 Genetic Variants and the Susceptibility to Anti-Tuberculosis Drug-Induced Liver Injury in a Western Chinese Population.

Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.

The Association Between HLA-DQB1 Polymorphism and Antituberculosis Drug-Induced Liver Injury: a Case-Control Study.

The relationship between polymorphisms of N-acetyltransferase 2 genes and anti-tuberculosis drug induced hepatic-injury